Carrier-Free Silibinin/Sorafenib Microparticles Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Fatty Acid Metabolism

Carrier-Free Silibinin/Sorafenib Microparticles Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating Fatty Acid Metabolism

Feifei Han,1,* Haiping Wang,1,2,* Li Wang,1 Limei Fan,1 Sibei Peng,1 Xiaoying Hou,1,2 Xiji Shu,1,2 Binlian Sun,1,2 Yuchen Liu1,2 1Cancer Institute, School of Medicine, Jianghan University, Wuhan, Hubei, 430056, People’s Republic of China; 2Hubei Key Laboratory of Cognitive an...

Full description

Saved in:
Bibliographic Details
Main Authors: Han F, Wang H, Wang L, Fan L, Peng S, Hou X, Shu X, Sun B, Liu Y
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:International Journal of Nanomedicine
Subjects:
Metabolic dysfunction-associated steatotic liver disease
Silibinin
Sorafenib
Self-assembled carrier-free microparticles
Fatty acid metabolism
Online Access:https://www.dovepress.com/carrier-free-silibininsorafenib-microparticles-alleviate-metabolic-dys-peer-reviewed-fulltext-article-IJN
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/carrier-free-silibininsorafenib-microparticles-alleviate-metabolic-dys-peer-reviewed-fulltext-article-IJN

Similar Items